EUVIMEDEUVIMED entdecken
Crossref

Modulation of keap-1/Nrf2/HO-1 and NF-ĸb/caspase-3 signaling pathways by dihydromyricetin ameliorates sodium valproate-induced liver injury

Doaa Emad, Asmaa M A Bayoumi, Sahar M Gebril, Doaa Mohamed Elroby Ali, Shaimaa Waz

Archives of Biochemistry and Biophysics · 2024

DOI: 10.1016/j.abb.2024.110084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2024. Verfasst von Doaa Emad und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, Sohag University, Sohag, Egypt. Electronic address: doaa.roshdy2018@pharm.sohag.edu.eg. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Signal Transduction, Flavonols, NF-kappa B. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 66 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nuclear factor erythroid factor 2 (Nrf2) is the key regulatory of the antioxidant response elements. Also, Nrf2 interacts with nuclear factor kappa B (NF-ĸB) to inhibit subsequent inflammatory cascade. Activation of Nrf2 signaling ameliorates drug-induced liver injury. Sodium valproate (SVP) is an anti-epilepsy drug with a hepatotoxic adverse effect that restricts its clinical use. In this study, coadministration of Dihydromyricetin (DHM), a natural flavonoid, with SVP to rats upregulated gene expression of Nrf2 and its downstream gene, heme oxygenase 1 (HO-1), while suppressed the Nrf2 repressor, Keap-1. Additionally, DHM led to downregulation of proinflammatory factors in liver tissues, including NF-ĸB, interleukin 1 beta (IL-1β), and tumor necrosis factor alpha (TNF-α). This was accompanied by a decrease in the proapoptotic protein (cleaved caspase-3) expression level. Furthermore, biochemical and histopathological studies showed that DHM treatment improved liver function and lipid profile while decreased inflammatory cell infiltration, congestion, and hepatocellular damage. According to our knowledge, prior research has not examined the protective effect of DHM on the liver injury induced by SVP. Consequently, this study provides DHM as a promising herbal medication that, when used with SVP, can prevent its induced hepatotoxicity owing to its potential anti-oxidative, anti-inflammatory, and anti-apoptotic properties.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-E2-Related Factor 2Signal TransductionFlavonolsNF-kappa BValproic AcidChemical and Drug Induced Liver InjuryKelch-Like ECH-Associated Protein 1Caspase 3AnimalsMaleRatsLiverRats, Sprague-DawleyHeme Oxygenase (Decyclizing)Heme Oxygenase-1

Stichwörter der Autor:innen

DihydromyricetinHepatotoxicityNF-ĸBNrf2Sodium valproate

Substanzen

dihydromyricetinNF-E2-Related Factor 2FlavonolsNF-kappa BValproic AcidKelch-Like ECH-Associated Protein 1Caspase 3KEAP1 protein, ratNfe2l2 protein, ratHmox1 protein, rat

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Pharmacy, Sohag University, Sohag, Egypt. Electronic address: doaa.roshdy2018@pharm.sohag.edu.eg.
  • Department of Biochemistry, Faculty of Pharmacy, Minia University, El-Minia, 61511, Egypt. Electronic address: asmaa_bayoumi@mu.edu.eg.
  • Department of Histology and Cell biology, Faculty of Medicine, Sohag University, Sohag, Egypt. Electronic address: Sahermohamed@med.sohag.edu.eg.
  • Department of Biochemistry, Faculty of Pharmacy, Sohag University, Sohag, Egypt. Electronic address: doaa.elroby@pharm.sohag.edu.eg.
  • Department of Biochemistry, Faculty of Pharmacy, Minia University, El-Minia, 61511, Egypt. Electronic address: shaimaaminia@mu.edu.eg.

Zitieren

APA

Emad, D., Bayoumi, A. M. A., Gebril, S. M., Ali, D. M. E., & Waz, S. (2024). Modulation of keap-1/Nrf2/HO-1 and NF-ĸb/caspase-3 signaling pathways by dihydromyricetin ameliorates sodium valproate-induced liver injury. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2024.110084

Vancouver

Emad D, Bayoumi AMA, Gebril SM, Ali DME, Waz S. Modulation of keap-1/Nrf2/HO-1 and NF-ĸb/caspase-3 signaling pathways by dihydromyricetin ameliorates sodium valproate-induced liver injury. Archives of Biochemistry and Biophysics. 2024. doi:10.1016/j.abb.2024.110084

BibTeX
@article{Emad2024,
  author = {Emad, Doaa and Bayoumi, Asmaa M A and Gebril, Sahar M and Ali, Doaa Mohamed Elroby and Waz, Shaimaa},
  title = {Modulation of keap-1/Nrf2/HO-1 and NF-ĸb/caspase-3 signaling pathways by dihydromyricetin ameliorates sodium valproate-induced liver injury},
  journal = {Archives of Biochemistry and Biophysics},
  year = {2024},
  doi = {10.1016/j.abb.2024.110084}
}
Kostenlos starten →